Two different STAT1 gain-of-function mutations lead to diverse IFN-γ-mediated gene expression

被引:13
|
作者
Ovadia, Adi [1 ,2 ,3 ,4 ]
Sharfe, Nigel [1 ,2 ,3 ,4 ]
Hawkins, Cynthia [5 ]
Laughlin, Suzanne [6 ]
Roifman, Chaim M. [1 ,2 ,3 ,4 ]
机构
[1] Hosp Sick Children, Dept Paediat, Div Immunol & Allergy, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Hosp Sick Children, Canadian Ctr Primary Immunodeficiency, Toronto, ON, Canada
[4] Hosp Sick Children, Jeffrey Modell Res Lab Diag Primary Immunodeficie, Toronto, ON, Canada
[5] Hosp Sick Children, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[6] Hosp Sick Children, Dept Radiol, Toronto, ON, Canada
来源
NPJ GENOMIC MEDICINE | 2018年 / 3卷
关键词
UNDERLIE;
D O I
10.1038/s41525-018-0063-6
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Signal transducer and activator of transcription 1 (STAT1) regulates multiple biological processes downstream of a variety of cytokine receptors in many cell types. Heterozygous gain-of-function (GOF) mutations in STAT1 have been associated with a diverse phenotype encompassing chronic mucocutaneous candidiasis (CMCC) and declining immunity. There is no dear correlation between STAT1 domain-specific mutations and phenotype, and it remains unclear why GOF mutations in STAT1 result in such a wide spectrum of clinical presentations. To begin exploring this dilemma, we have studied the patterns of gene expression mediated by two different GOF mutations. Analysis of IFN-gamma response elements using RNA microarrays in cells transfected with the rare H629Y mutant or the common R274G mutant showed distinct patterns of gene expression. We show here that the impact of GOF mutations in STAT1 is variant-specific. This difference in gene expression may explain the diversity in clinical manifestations experienced by these patients.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Two different STAT1 gain-of-function mutations lead to diverse IFN-γ-mediated gene expression
    Adi Ovadia
    Nigel Sharfe
    Cynthia Hawkins
    Suzanne Laughlin
    Chaim M. Roifman
    npj Genomic Medicine, 3
  • [2] Dysregulated IFN-? signals promote autoimmunity in STAT1 gain-of-function syndrome
    Largent, Andrea D.
    Lambert, Katharina
    Chiang, Kristy
    Shumlak, Natali
    Liggitt, Denny
    Oukka, Mohammed
    Torgerson, Troy R.
    Buckner, Jane H.
    Allenspach, Eric J.
    Rawlings, David J.
    Jackson, Shaun W.
    SCIENCE TRANSLATIONAL MEDICINE, 2023, 15 (703)
  • [3] STAT1 gain-of-function compromises skin host defense in the context of IFN-γ signaling
    Niehues, Hanna
    Rosler, Berenice
    van der Krieken, Danique A.
    van Vlijmen-Willems, Ivonne M. J. J.
    Rodijk-Olthuis, Diana
    Peppelman, Malou
    Schalkwijk, Joost
    van den Bogaard, Ellen H. J.
    Zeeuwen, Patrick L. J. M.
    van de Veerdonk, Frank L.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (04) : 1626 - +
  • [4] STAT1 gain-of-function compromises skin host defense in the context of IFN-γ signaling
    Niehues, H.
    Rosler, B.
    van der Krieken, D.
    van Vlijmen-Willems, I.
    Rodijk-Olthuis, D.
    Peppelman, M.
    Schalkwijk, J.
    Zeeuwen, P.
    van den Bogaard, E.
    van de Veerdonk, F.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (09) : S247 - S247
  • [5] A novel gain-of-function STAT1 mutation resulting in basal phosphorylation of STAT1 and increased distal IFN-γ-mediated responses in chronic mucocutaneous candidiasis
    Martinez-Martinez, Laura
    Martinez-Saavedra, Maria Teresa
    Fuentes-Prior, Pablo
    Barnadas, Maria
    Victoria Rubiales, Maria
    Noda, Judith
    Badell, Isabel
    Rodriguez-Gallego, Carlos
    de la Calle-Martina, Oscar
    MOLECULAR IMMUNOLOGY, 2015, 68 (02) : 597 - 605
  • [6] GAIN-OF-FUNCTION MUTATIONS OF STAT1 IN JAPANESE PATIENTS WITH CMCD
    Hirata, O.
    Tsumura, M.
    Mizoguchi, Y.
    Okada, S.
    Minegishi, S.
    Morio, T.
    Kobayashi, M.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 : 104 - 105
  • [7] Gain-of-function STAT1 mutations are associated with intracranial aneurysms
    Dadak, Mete
    Jacobs, Roland
    Skuljec, Jelena
    Jirmo, Adan Chari
    Yildiz, Oezlem
    Donnerstag, Frank
    Baerlecken, Niklas Thomas
    Schmidt, Reinhold Ernst
    Lanfermann, Heinrich
    Skripuletz, Thomas
    Schwenkenbecher, Philipp
    Kleinschnitz, Christoph
    Tumani, Hayrettin
    Stangel, Martin
    Pul, Refik
    CLINICAL IMMUNOLOGY, 2017, 178 : 79 - 85
  • [8] STAT1 Gain-of-Function Mutations Cause High Total STAT1 Levels With Normal Dephosphorylation
    Zimmerman, Ofer
    Olbrich, Peter
    Freeman, Alexandra F.
    Rosen, Lindsey B.
    Uzel, Gulbu
    Zerbe, Christa S.
    Rosenzweig, Sergio D.
    Kuehn, Hye Sun
    Holmes, Kevin L.
    Stephany, David
    Ding, Li
    Sampaio, Elizabeth P.
    Hsu, Amy P.
    Holland, Steven M.
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [9] STAT1 gain-of-function and chronic demodicosis
    Molho-Pessach, Vered
    Meltser, Arnon
    Kamshov, Adaia
    Ramot, Yuval
    Zlotogorski, Abraham
    PEDIATRIC DERMATOLOGY, 2020, 37 (01) : 153 - 155
  • [10] Identification of Two New Gain-of-Function STAT1 Mutations in the DNA-Binding Domain
    Frans, G.
    Moens, L.
    Schaballie, H.
    Wuyts, G.
    Dillaerts, D.
    Bossuyt, X.
    Ceuppens, J.
    Meyts, I.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S241 - S241